Therefore, higher expression of UBA1 may affect the prognosis of haematological malignancies (DLBCL and AML) by promoting sustained cell proliferation, inhibiting cell apoptosis and ultimately leading to tumour formation. Here, UBA1 is linked to acute myeloid leukemia.